Braun Stacey Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-94,289
| Closed | -$11.4M | – | 123 |
|
|
2024
Q1 | $11.4M | Sell |
94,289
-3,734
| -4% | -$450K | 0.45% | 83 |
|
|
2023
Q4 | $12.1M | Sell |
98,023
-11,901
| -11% | -$1.46M | 0.54% | 76 |
|
|
2023
Q3 | $14.2M | Sell |
109,924
-10,563
| -9% | -$1.37M | 0.69% | 67 |
|
|
2023
Q2 | $14.9M | Sell |
120,487
-118,803
| -50% | -$14.7M | 0.69% | 70 |
|
|
2023
Q1 | $35M | Buy |
239,290
+120,749
| +102% | +$17.7M | 0.92% | 50 |
|
|
2022
Q4 | $18.9M | Buy |
118,541
+242
| +0.2% | +$38.6K | 1.08% | 39 |
|
|
2022
Q3 | $15.8M | Sell |
118,299
-4,006
| -3% | -$534K | 0.96% | 46 |
|
|
2022
Q2 | $19.1M | Buy |
122,305
+8,942
| +8% | +$1.4M | 1.09% | 27 |
|
|
2022
Q1 | $17.6M | Buy |
113,363
+66,503
| +142% | +$10.4M | 0.73% | 68 |
|
|
2021
Q4 | $5.97M | Buy |
+46,860
| New | +$5.97M | 0.22% | 101 |
|
|
2016
Q1 | – | Sell |
-7,338
| Closed | -$1.03M | – | 154 |
|
|
2015
Q4 | $1.03M | Sell |
7,338
-73,899
| -91% | -$10.4M | 0.06% | 108 |
|
|
2015
Q3 | $10.8M | Sell |
81,237
-19,536
| -19% | -$2.59M | 0.72% | 76 |
|
|
2015
Q2 | $17.7M | Sell |
100,773
-13,284
| -12% | -$2.34M | 0.76% | 59 |
|
|
2015
Q1 | $19.7M | Sell |
114,057
-28,688
| -20% | -$4.96M | 1.15% | 22 |
|
|
2014
Q4 | $23.4M | Sell |
142,745
-11,540
| -7% | -$1.89M | 1.42% | 4 |
|
|
2014
Q3 | $24.8M | Sell |
154,285
-8,634
| -5% | -$1.39M | 1.53% | 3 |
|
|
2014
Q2 | $24M | Sell |
162,919
-32,853
| -17% | -$4.83M | 1.42% | 5 |
|
|
2014
Q1 | $27.1M | Sell |
195,772
-75,318
| -28% | -$10.4M | 1.59% | 4 |
|
|
2013
Q4 | $34.3M | Sell |
271,090
-42,120
| -13% | -$5.33M | 1.96% | 2 |
|
|
2013
Q3 | $28.8M | Buy |
313,210
+3,300
| +1% | +$304K | 1.77% | 2 |
|
|
2013
Q2 | $21.3M | Buy |
+309,910
| New | +$21.3M | 1.34% | 10 |
|